Last filing: Jul 10, 2026.
Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 0 of the 13 calendar months from Oct 2025 to Oct 2026.
- No sale on record before this period.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| Edwards Lifesciences (EW) | CVP, Chief Financial Officer | Jul 10, 2026 | Jul 10, 2026 |
| Viatris (VTRS) | Chief Financial Officer | Mar 5, 2024 | Mar 10, 2026 |
Recent filings
The last 4 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.
- Jul 9, 2026, Edwards Lifesciences: 99,920 shares granted. 1 filing: 1
- Mar 6, 2026, Viatris: 41,711 shares vested; 24,213 shares withheld by the company for taxes; 2,071 shares vested or acquired by exercising options. 1 filing: 1
- Mar 4, 2026, Viatris: 31,149 shares vested; 18,850 shares withheld by the company for taxes; 2,935 shares vested or acquired by exercising options. 1 filing: 1
- Jan 1, 2026, Viatris: 23,085 shares vested; 14,598 shares withheld by the company for taxes; 2,175 shares vested or acquired by exercising options. 1 filing: 1
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.